Scientists might have been looking for ovarian cancer in the wrong place, new breakthrough study suggests
Ovarian cancer is highly deadly, in part because it tends to be noticed so late
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists might have been looking for ovarian cancer in the wrong place, according to a breakthrough new study.
The findings could offer new ways of preventing and treating the disease, which is one of the biggest killers of women.
Researchers had long suspected that ovarian cancer originates in the fallopian tubes, which run between the ovaries and the uterus. And the new study suggests that is correct, offering new ways of spotting and dealing with the disease.
Ovarian cancer is the fifth largest cause of cancer deaths for women. And that is partly because it is often spotted so late, meaning that only 30 per cent of women with the disease live for 10 more years.
Scientists now say that those problems might have arisen because researchers were looking in the wrong place, at the wrong tissue. The new discovery could make it much easier to spot the cancer, and earlier, they said.
"Ovarian cancer treatments have not changed much in many decades, and this may be, in part, because we have been studying the wrong tissue of origin for these cancers," said Victor Velculescu, a professor of oncology at the Johns Hopkins Kimmel Cancer Center who led the study.
"If studies in larger groups of women confirm our finding that the fallopian tubes are the site of origin of most ovarian cancer, then this could result in a major change in the way we manage this disease for patients at risk."
The research, which only looked at a relatively small number of women, took cells from a range of people who had been diagnosed with the disease, and looked at the genetic variations in the tissues in their ovaries and fallopian tubes.
That work led them to conclude that while the cancers might first be observed in the ovary, they appeared to have begun in the fallopian tubes. The cancers were the result of a "seeding event", they said, which began there.
Once the cancer reached the ovaries, it progressed quickly, very soon becoming metastatic and able to spread through the rest of the body. "This aligns with what we see in the clinic, that newly-diagnosed ovarian cancer patients most often already have widespread disease," said Velculescu.
Researchers hope that further work will allow them to check those findings – and, if they are correct, save women the invasive and dangerous procedures of hormone treatment or the removal of their ovaries. It could also allow them to more quickly and easily detect the disease, they said, allowing them to detect the cancer more quickly and so potentially avoid deaths.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments